T

Terray Therapeutics, Inc.

Generative AI-powered small-molecule drug discovery platform

Associate Scientist - Resynthesis

Translational Research & Bench BiologyUpdated on Nov 13
Full-timeMonrovia, CA, USA$85k - $142k /yrIn-person

About the Job

Requirements

  • A Master's degree in chemistry or a related discipline with at least 3 to 5 years of relevant industrial or commercial experience, or a Bachelor's degree in chemistry or a related discipline with 6 to 10 years of relevant industrial or commercial experience.
  • Extensive experience in synthetic organic chemistry.
  • Experience working closely in a team, preferably in a fast-paced environment.
  • Ability to work with peers and independently to execute time-sensitive schedules.
  • Experience with solution- and solid-phase organic synthesis and/or DNA-encoded libraries.
  • Experience with high-throughput organic synthesis and datasets.
  • Strong written and verbal communication and interpersonal skills.
  • Excellent attention to detail.

Responsibilities

  • Follow Standard Operating Procedures and laboratory safety standards to conduct high-quality, rapid, high-throughput production resynthesis with automated integrations.
  • Collaborate with upstream and downstream stakeholders to execute synthesis schedules according to inter-team priorities and follow up on compound deliverables.
  • Partner with R&D groups to adapt and screen high-throughput organic synthesis conditions.
  • Execute frequent compound handoffs and follow-up experimentation, including alternative synthesis routes for multi-step compounds.
  • Document experimentation in detail, including experimental notebooks, synthesis metadata, inventory consumption, and final purified compound information.

Desired Qualifications

  • Experience with liquid-handling automation.

About the Company

Terray Therapeutics, Inc.

Generative AI-powered small-molecule drug discovery platform

Terray Therapeutics combines wet-lab experimentation with AI to discover small molecule drugs. It builds a data-driven platform that collects over two billion target–ligand binding measurements, adding about 150 million per month, to train deep learning models that predict molecular properties. Its rapid design-make-test-analyze cycle takes under a month per target, allowing millions of molecules to be measured and enabling the identification of potent, selective compounds across many targets. With a focus on immunology and partnerships with pharmaceutical and biotech companies, Terray pursues internal programs and collaborations to accelerate discovery of safe, effective small molecules.

Company size
51-200
Company stage
Series B
Total funding
$195M
Headquarters
Pasadena, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Terray Therapeutics, Inc.

See more jobs